• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Allurion Technologies

Allurion relaunches weight loss balloon in France

February 13, 2025 By Sean Whooley

Allurion Technologies (NYSE:ALUR) today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume sales. Natick Massachusetts–based Allurion develops the AI-powered gastric balloon for weight loss. The swallowable balloon requires no surgery, endoscopy or anesthesia. Once swallowed, the balloon fills and remains in the stomach for approximately four months before self-emptying […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Health Technology, Machine Learning (ML), Software / IT, Weight loss Tagged With: Allurion Technologies

Allurion submits weight loss balloon modules to the FDA for premarket approval

October 23, 2024 By Sean Whooley

Allurion Technologies (NYSE:ALUR) announced today that it submitted three modules for its weight loss balloon to the FDA for premarket approval (PMA). Natick, Massachusetts-based Allurion expects to file the fourth and final module of the PMA early next year. That module contains clinical data from the company’s AUDACITY trial. AUDACITY evaluates the balloon in 550 […]

Filed Under: Artificial Intelligence (AI), Digital Health, Food & Drug Administration (FDA), Health Technology, Machine Learning (ML), Pre-Market Approval (PMA), Regulatory/Compliance, Software / IT, Weight loss Tagged With: Allurion Technologies

Allurion could face NYSE delisting

August 16, 2024 By Sean Whooley

Allurion Technologies (NYSE:ALUR) announced that it received notice from the New York Stock Exchange that it fell out of compliance with listing standards. The NYSE notified Allurion that its stock’s average closing price fell below $1 per share over 30 consecutive trading days ending Aug. 8. This notice does not result in the immediate delisting […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Health Technology, Machine Learning (ML), Software / IT, Wall Street Beat, Weight loss Tagged With: Allurion Technologies

Allurion pulls weight loss balloon from the French market

August 6, 2024 By Sean Whooley

Allurion Technologies (NYSE:ALUR) announced today that it suspended sales of its Allurion Balloon from the market in France. The company agreed to suspend sales following a request from the National Medicines Safety Agency (ANSM) in the country. It now proceeds with the withdrawal of its devices from the market, pending the implementation of an action […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Featured, Health Technology, Implants, Machine Learning (ML), Weight loss Tagged With: Allurion Technologies

Allurion study says balloon delivers 22% weight loss at one year

June 11, 2024 By Sean Whooley

Allurion (NYSE:ALUR) today announced data highlighting the success of its balloon technology for weight loss. Natick Massachusetts–based Allurion develops a gastric balloon for weight loss. The swallowable balloon requires no surgery, endoscopy or anesthesia. Once swallowed, the balloon fills and remains in the stomach for approximately four months before self-emptying and passing out naturally. Allurion […]

Filed Under: Artificial Intelligence (AI), Digital Health, Featured, Health Technology, Machine Learning (ML), Software / IT, Weight loss Tagged With: Allurion Technologies

Allurion appoints new chief operating officer

June 5, 2024 By Danielle Kirsh

Allurion (NYSE:ALUR) today announced it appointed Ojas Buch as chief operating officer, effective immediately. Buch will lead the company’s research and development, manufacturing and operations, quality and regulatory, business development, and innovation functions. The company said he will provide strategic and execution-focused guidance to help the company achieve major milestones for its Allurion Gastric Balloon. “We […]

Filed Under: Weight loss Tagged With: Allurion Technologies

Allurion closes $48 million financing

April 17, 2024 By Sean Whooley

Allurion (NYSE:ALUR) announced today that it closed a financing of convertible senior secured notes worth $48 million. The company entered into the financing with certain entities managed by RTW Investments. It intends to use proceeds to repay obligations under its existing term loan with Fortress Credit Corp. This reduces the company’s interest expense and increases […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Funding Roundup, Health Technology, Patient Monitoring, Software / IT, Weight loss Tagged With: Allurion Technologies

UK NHS trust treats first patients with Allurion weight loss balloon

January 23, 2024 By Sean Whooley

Allurion (NYSE:ALUR) announced today that the Somerset NHS Foundation Trust introduced its gastric balloon for weight loss. This marks the first NHS trust in the UK and the first non-private sector organization in the world to introduce the balloon. Natick Massachusetts-based Allurion designed the swallowable balloon to require no surgery, endoscopy or anaesthesia. Once swallowed, […]

Filed Under: Business/Financial News, Health Technology, Patient Monitoring, Software / IT, Weight loss Tagged With: Allurion Technologies

Weight loss balloon maker Allurion goes public on NYSE through SPAC merger

August 3, 2023 By Sean Whooley

Allurion Technologies announced that it completed a SPAC merger and began trading on the New York Stock Exchange. Natick, Massachusetts-based Allurion went public on Aug. 2 under the ALUR ticker. The business combination took place with Compute Health Acquisition Corp, a special purpose acquisition company (SPAC). Allurion develops an artificial intelligence-powered weight loss program. Its program […]

Filed Under: Business/Financial News, Featured, Health Technology, Mergers & Acquisitions, News Well, Software / IT, Wall Street Beat, Weight loss Tagged With: Allurion Technologies, SPAC

Medtronic, Allurion partner on AI-based weight loss tech

June 22, 2023 By Sean Whooley

Allurion announced today that it entered into a pilot collaboration with Medtronic . Allurion and Medtronic inked a sales agency agreement in the Central and Eastern Europe, Middle East, and Africa (CEMA) region. The agreement aims to expand access to Allurion’s artificial intelligence-powered weight loss program. It enables Allurion to offer its Allurion Balloon and […]

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, News Well, Software / IT, Weight loss Tagged With: Allurion Technologies, Medtronic

Allurion Technologies appoints three new executives

January 9, 2020 By Danielle Kirsh

Allurion Technologies this week said it appointed three new executives. Whitney Cypes was appointed VP of global marketing. Cypes has more than 15 years of global marketing of medical devices experience. Prior to joining Allurion, Cypes was the senior director of marketing at Insulet. She has also held a number of leadership roles at Hologic, […]

Filed Under: Business/Financial News, Weight loss Tagged With: Allurion Technologies

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy